Qi Wang , Xiaomeng Tang , Wenying Qiao , Lina Sun , Han Shi , Dexi Chen , Bin Xu , Yanmin Liu , Juan Zhao , Chunyang Huang , Ronghua Jin
{"title":"基于机器学习的与原发性胆汁性胆管炎发展为肝硬化相关的肠道微生物组特征描述","authors":"Qi Wang , Xiaomeng Tang , Wenying Qiao , Lina Sun , Han Shi , Dexi Chen , Bin Xu , Yanmin Liu , Juan Zhao , Chunyang Huang , Ronghua Jin","doi":"10.1016/j.micinf.2024.105368","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div><span>Primary biliary cholangitis (PBC) is associated closely with the </span>gut microbiota<span><span>. This study aimed to explore the characteristics of the gut microbiota after the progress of PBC to </span>cirrhosis.</span></div></div><div><h3>Method</h3><div>This study focuses on utilizing the 16S rRNA<span> gene sequencing method to screen for differences in gut microbiota<span> in PBC patients who progress to cirrhosis. Then, we divided the data into training and verification sets and used seven different machine learning (ML) models to validate them respectively, calculating and comparing the accuracy, F1 score, precision, and recall, and screening the dominant intestinal flora affecting PBC cirrhosis.</span></span></div></div><div><h3>Result</h3><div><span>PBC cirrhosis patients showed decreased diversity and richness of gut microbiota. Additionally, there are alterations in the composition of gut microbiota in PBC cirrhosis patients. The abundance of </span><span><span>Faecalibacterium</span></span> and <em>Gemmiger</em> bacteria significantly decreases, while the abundance of <span><span>Veillonella</span></span> and <span><span>Streptococcus</span></span> significantly increases. Furthermore, machine learning methods identify <span><span>Streptococcus</span></span> and <em>Gemmiger</em> as the predominant gut microbiota in PBC patients with cirrhosis, serving as non-invasive biomarkers (AUC = 0.902).</div></div><div><h3>Conclusion</h3><div>Our study revealed that PBC cirrhosis patients gut microbiota composition and function have significantly changed. <em>Streptococcus</em> and <em>Gemmiger</em> may become a non-invasive biomarker for predicting the progression of PBC progress to cirrhosis.</div></div>","PeriodicalId":18497,"journal":{"name":"Microbes and Infection","volume":"26 8","pages":"Article 105368"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Machine learning-based characterization of the gut microbiome associated with the progression of primary biliary cholangitis to cirrhosis\",\"authors\":\"Qi Wang , Xiaomeng Tang , Wenying Qiao , Lina Sun , Han Shi , Dexi Chen , Bin Xu , Yanmin Liu , Juan Zhao , Chunyang Huang , Ronghua Jin\",\"doi\":\"10.1016/j.micinf.2024.105368\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div><span>Primary biliary cholangitis (PBC) is associated closely with the </span>gut microbiota<span><span>. This study aimed to explore the characteristics of the gut microbiota after the progress of PBC to </span>cirrhosis.</span></div></div><div><h3>Method</h3><div>This study focuses on utilizing the 16S rRNA<span> gene sequencing method to screen for differences in gut microbiota<span> in PBC patients who progress to cirrhosis. Then, we divided the data into training and verification sets and used seven different machine learning (ML) models to validate them respectively, calculating and comparing the accuracy, F1 score, precision, and recall, and screening the dominant intestinal flora affecting PBC cirrhosis.</span></span></div></div><div><h3>Result</h3><div><span>PBC cirrhosis patients showed decreased diversity and richness of gut microbiota. Additionally, there are alterations in the composition of gut microbiota in PBC cirrhosis patients. The abundance of </span><span><span>Faecalibacterium</span></span> and <em>Gemmiger</em> bacteria significantly decreases, while the abundance of <span><span>Veillonella</span></span> and <span><span>Streptococcus</span></span> significantly increases. Furthermore, machine learning methods identify <span><span>Streptococcus</span></span> and <em>Gemmiger</em> as the predominant gut microbiota in PBC patients with cirrhosis, serving as non-invasive biomarkers (AUC = 0.902).</div></div><div><h3>Conclusion</h3><div>Our study revealed that PBC cirrhosis patients gut microbiota composition and function have significantly changed. <em>Streptococcus</em> and <em>Gemmiger</em> may become a non-invasive biomarker for predicting the progression of PBC progress to cirrhosis.</div></div>\",\"PeriodicalId\":18497,\"journal\":{\"name\":\"Microbes and Infection\",\"volume\":\"26 8\",\"pages\":\"Article 105368\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbes and Infection\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1286457924001047\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbes and Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1286457924001047","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Machine learning-based characterization of the gut microbiome associated with the progression of primary biliary cholangitis to cirrhosis
Background
Primary biliary cholangitis (PBC) is associated closely with the gut microbiota. This study aimed to explore the characteristics of the gut microbiota after the progress of PBC to cirrhosis.
Method
This study focuses on utilizing the 16S rRNA gene sequencing method to screen for differences in gut microbiota in PBC patients who progress to cirrhosis. Then, we divided the data into training and verification sets and used seven different machine learning (ML) models to validate them respectively, calculating and comparing the accuracy, F1 score, precision, and recall, and screening the dominant intestinal flora affecting PBC cirrhosis.
Result
PBC cirrhosis patients showed decreased diversity and richness of gut microbiota. Additionally, there are alterations in the composition of gut microbiota in PBC cirrhosis patients. The abundance of Faecalibacterium and Gemmiger bacteria significantly decreases, while the abundance of Veillonella and Streptococcus significantly increases. Furthermore, machine learning methods identify Streptococcus and Gemmiger as the predominant gut microbiota in PBC patients with cirrhosis, serving as non-invasive biomarkers (AUC = 0.902).
Conclusion
Our study revealed that PBC cirrhosis patients gut microbiota composition and function have significantly changed. Streptococcus and Gemmiger may become a non-invasive biomarker for predicting the progression of PBC progress to cirrhosis.
期刊介绍:
Microbes and Infection publishes 10 peer-reviewed issues per year in all fields of infection and immunity, covering the different levels of host-microbe interactions, and in particular:
the molecular biology and cell biology of the crosstalk between hosts (human and model organisms) and microbes (viruses, bacteria, parasites and fungi), including molecular virulence and evasion mechanisms.
the immune response to infection, including pathogenesis and host susceptibility.
emerging human infectious diseases.
systems immunology.
molecular epidemiology/genetics of host pathogen interactions.
microbiota and host "interactions".
vaccine development, including novel strategies and adjuvants.
Clinical studies, accounts of clinical trials and biomarker studies in infectious diseases are within the scope of the journal.
Microbes and Infection publishes articles on human pathogens or pathogens of model systems. However, articles on other microbes can be published if they contribute to our understanding of basic mechanisms of host-pathogen interactions. Purely descriptive and preliminary studies are discouraged.